Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems. |
Anwar A, Dehn D, Siegel D, Kepa JK, Tang LJ, Pietenpol JA, Ross D |
The Journal of biological chemistry. 2003 ; 278 (12) : 10368-10373. |
PMID 12529318 |
|
NQO1 stabilizes p53 through a distinct pathway. |
Asher G, Lotem J, Kama R, Sachs L, Shaul Y |
Proceedings of the National Academy of Sciences of the United States of America. 2002 ; 99 (5) : 3099-3104. |
PMID 11867746 |
|
Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines. |
Beall HD, Murphy AM, Siegel D, Hargreaves RH, Butler J, Ross D |
Molecular pharmacology. 1995 ; 48 (3) : 499-504. |
PMID 7565631 |
|
The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. |
Beyer RE, Segura-Aguilar J, Di Bernardo S, Cavazzoni M, Fato R, Fiorentini D, Galli MC, Setti M, Landi L, Lenaz G |
Proceedings of the National Academy of Sciences of the United States of America. 1996 ; 93 (6) : 2528-2532. |
PMID 8637908 |
|
DT-diaphorase. |
Ernster, L |
Meth Enzymol. 1967 ; 10 : 309-317. |
|
Structure-based development of anticancer drugs: complexes of NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones. |
Faig M, Bianchet MA, Winski S, Hargreaves R, Moody CJ, Hudnott AR, Ross D, Amzel LM |
Structure (London, England : 1993). 2001 ; 9 (8) : 659-667. |
PMID 11587640 |
|
NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations. |
Gaedigk A, Tyndale RF, Jurima-Romet M, Sellers EM, Grant DM, Leeder JS |
Pharmacogenetics. 1998 ; 8 (4) : 305-313. |
PMID 9731717 |
|
An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues. |
Gasdaska PY, Fisher H, Powis G |
Cancer research. 1995 ; 55 (12) : 2542-2547. |
PMID 7780966 |
|
The NAD(P)H:quinone oxidoreductase locus in human colon carcinoma HCT 116 cells resistant to mitomycin C. |
Hu LT, Stamberg J, Pan S |
Cancer research. 1996 ; 56 (22) : 5253-5259. |
PMID 8912865 |
|
Human NAD(P)H:quinone oxidoreductase (NQO1) gene structure and induction by dioxin. |
Jaiswal AK |
Biochemistry. 1991 ; 30 (44) : 10647-10653. |
PMID 1657151 |
|
Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16. |
Jaiswal AK, McBride OW, Adesnik M, Nebert DW |
The Journal of biological chemistry. 1988 ; 263 (27) : 13572-13578. |
PMID 2843525 |
|
Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. |
Kelsey KT, Ross D, Traver RD, Christiani DC, Zuo ZF, Spitz MR, Wang M, Xu X, Lee BK, Schwartz BS, Wiencke JK |
British journal of cancer. 1997 ; 76 (7) : 852-854. |
PMID 9328142 |
|
Regulation and function of NAD(P)H:quinone oxidoreductase (NQO1). |
Kepa JK, Traver RD, Siegel D, Winski SL, and Ross D |
Reviews in Toxicology. 1997. |
|
Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. |
Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM, Smith MT |
Blood. 1999 ; 94 (2) : 803-807. |
PMID 10397748 |
|
The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction. |
Li R, Bianchet MA, Talalay P, Amzel LM |
Proceedings of the National Academy of Sciences of the United States of America. 1995 ; 92 (19) : 8846-8850. |
PMID 7568029 |
|
DT-diaphorase: purification, properties, and function. |
Lind C, Cadenas E, Hochstein P, Ernster L |
Methods in enzymology. 1990 ; 186 : 287-301. |
PMID 2233301 |
|
NAD(P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin. |
Long DJ 2nd, Waikel RL, Wang XJ, Roop DR, Jaiswal AK |
Journal of the National Cancer Institute. 2001 ; 93 (15) : 1166-1170. |
PMID 11481389 |
|
A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. |
Moran JL, Siegel D, Ross D |
Proceedings of the National Academy of Sciences of the United States of America. 1999 ; 96 (14) : 8150-8155. |
PMID 10393963 |
|
Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia. |
Naoe T, Takeyama K, Yokozawa T, Kiyoi H, Seto M, Uike N, Ino T, Utsunomiya A, Maruta A, Jin-nai I, Kamada N, Kubota Y, Nakamura H, Shimazaki C, Horiike S, Kodera Y, Saito H, Ueda R, Wiemels J, Ohno R |
Clinical cancer research : an official journal of the American Association for Cancer Research. 2000 ; 6 (10) : 4091-4095. |
PMID 11051261 |
|
NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells. |
Pan SS, Forrest GL, Akman SA, Hu LT |
Cancer research. 1995 ; 55 (2) : 330-335. |
PMID 7812966 |
|
Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. |
Radjendirane V, Joseph P, Lee YH, Kimura S, Klein-Szanto AJ, Gonzalez FJ, Jaiswal AK |
The Journal of biological chemistry. 1998 ; 273 (13) : 7382-7389. |
PMID 9516435 |
|
NAD(P)H:quinone oxidoreductases. |
Ross D |
Encyclopedia of Molecular Medicine. 2001. |
|
Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies. |
Ross D, Beall H, Traver RD, Siegel D, Phillips RM, Gibson NW |
Oncology research. 1994 ; 6 (10-11) : 493-500. |
PMID 7620217 |
|
NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. |
Ross D, Kepa JK, Winski SL, Beall HD, Anwar A, Siegel D |
Chemico-biological interactions. 2000 ; 129 (1-2) : 77-97. |
PMID 11154736 |
|
NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. |
Ross D, Siegel D |
Methods in enzymology. 2004 ; 382 : 115-144. |
PMID 15047100 |
|
Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1. |
Siegel D, Anwar A, Winski SL, Kepa JK, Zolman KL, Ross D |
Molecular pharmacology. 2001 ; 59 (2) : 263-268. |
PMID 11160862 |
|
The reduction of alpha-tocopherolquinone by human NAD(P)H: quinone oxidoreductase: the role of alpha-tocopherolhydroquinone as a cellular antioxidant. |
Siegel D, Bolton EM, Burr JA, Liebler DC, Ross D |
Molecular pharmacology. 1997 ; 52 (2) : 300-305. |
PMID 9271353 |
|
Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1. |
Siegel D, McGuinness SM, Winski SL, Ross D |
Pharmacogenetics. 1999 ; 9 (1) : 113-121. |
PMID 10208650 |
|
Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues. |
Siegel D, Ross D |
Free radical biology & medicine. 2000 ; 29 (3-4) : 246-253. |
PMID 11035253 |
|
Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults. |
Smith MT, Wang Y, Kane E, Rollinson S, Wiemels JL, Roman E, Roddam P, Cartwright R, Morgan G |
Blood. 2001 ; 97 (5) : 1422-1426. |
PMID 11222389 |
|
NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. |
Traver RD, Horikoshi T, Danenberg KD, Stadlbauer TH, Danenberg PV, Ross D, Gibson NW |
Cancer research. 1992 ; 52 (4) : 797-802. |
PMID 1737339 |
|
Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). |
Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA, Ross D |
British journal of cancer. 1997 ; 75 (1) : 69-75. |
PMID 9000600 |
|
A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. |
Wiemels JL, Pagnamenta A, Taylor GM, Eden OB, Alexander FE, Greaves MF |
Cancer research. 1999 ; 59 (16) : 4095-4099. |
PMID 10463613 |
|
A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent. |
Winski SL, Hargreaves RH, Butler J, Ross D |
Clinical cancer research : an official journal of the American Association for Cancer Research. 1998 ; 4 (12) : 3083-3088. |
PMID 9865924 |
|